ReviewERJ open research2020
Treatment of severe stable COPD: the multidimensional approach of treatable traits.
Review in ERJ open research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed, 2 syntheses or guidelines pooled it, 50 citations in OpenAlex.
- Pooled it
- Chronic non-invasive ventilation for chronic obstructive pulmonary disease.The Cochrane database of systematic reviews · 2021Pooled it
- Fentanyl or morphine for persistent dyspnoea in COPD: a multicentre randomised crossover trial.The European respiratory journal · 2026Trial
- Surgical lung volume reduction eligibility in an emphysema patient pool referred for endoscopic treatment.BMC pulmonary medicine · 2025Observational
- Chronic noninvasive ventilation in COPD: towards the identification of a responder phenotype.ERJ open research · 2025Article
- Timing of lung transplant evaluation: considerations, barriers and alternatives.Current opinion in pulmonary medicine · 2025Review
- Translating a Home-Based Breathlessness Service: A Pilot Study of Feasibility, Person-Reported, and Hospital Use Outcomes.Journal of clinical medicine · 2025Article
- Home Noninvasive Ventilation Should Start at Home.American journal of respiratory and critical care medicine · 2025Article
- Patient-centered assessment of treatment for alpha-1 antitrypsin deficiency: literature review to identify concepts and measures for people with alpha1-antitrypsin deficiency.Orphanet journal of rare diseases · 2025Review
- Widening the selection criteria for lung volume reduction surgery.The European respiratory journal · 2025Article
- Comorbidities reduce survival and quality of life in COPD with severe lung hyperinflation.ERJ open research · 2024Article
- Interventional pulmonology for chronic inflammatory airway diseases.Chinese medical journal pulmonary and critical care medicine · 2024Review
- Exploring Molecular Mechanisms and Biomarkers in COPD: An Overview of Current Advancements and Perspectives.International journal of molecular sciences · 2024Review
- Article
- Lung volume reduction surgery is safe and feasible after initial endobronchial valve treatment for emphysema patients.Interdisciplinary cardiovascular and thoracic surgery · 2024Article
- Assessment of hyperinflation: comparison of Global Lung Function Initiative and European Community for Steel and Coal lung volume reference equations.ERJ open research · 2024Article
- Yiqigubiao pill treatment regulates Sirtuin 5 expression and mitochondrial function in chronic obstructive pulmonary disease.Journal of thoracic disease · 2024Article
- Deventilation Syndrome in Patients with Chronic Obstructive Pulmonary Disease Using Nocturnal Noninvasive Ventilation: What Are the Underlying Mechanisms?Respiration; international review of thoracic diseases · 2024Observational
- Severe COPD: Multidisciplinary Consultation to Get the Right Care at the Right Place.International journal of chronic obstructive pulmonary disease · 2024Article
- Aqueous dispersions of oxygen nanobubbles for potential application in inhalation therapy.Scientific reports · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Now that additional treatment options for severe chronic obstructive pulmonary disease (COPD) have emerged in recent years, patients with severe COPD should not be left in the rather hopeless situation of "there is nothing to improve" any more. Inertia or fatalism is a disservice to our patients. Ranging from advanced care planning to quite intense and demanding therapies such as multidisciplinary pulmonary rehabilitation, (endoscopic) lung volume reduction, chronic noninvasive ventilation and lung transplantation, caregivers should try to provide a personalised treatment for every severe COPD patient. In this review, we aim to describe the multidimensional approach to these patients at our centre along the lines of treatable traits leading to specific additional treatment modalities on top of standard care.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.